TrialDiabetic medicine : a journal of the British Diabetic Association2010

Safety and tolerability of high doses of taspoglutide, a once-weekly human GLP-1 analogue, in diabetic patients treated with metformin: a randomized double-blind placebo-controlled study.

R Ratner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.